Alpha-lipoic acid for IVF in women 35-45
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 35 and 45
- Your body mass index (BMI) is between 18 and 35
- You plan to use your own eggs for IVF treatment
- You do not have a known allergy to alpha-lipoic acid
- You do not have very low egg reserve (primary ovarian insufficiency) or severe uterus problems
- Neither you nor your partner has a known chromosomal condition or active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking melatonin (a natural sleep hormone) as a supplement can improve the health of cells surrounding your eggs (cumulus cells) and possibly lead to more successful IVF. It is for women aged 35 to 45 planning an IVF cycle.
This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.
This study tests whether a natural supplement called resveratrol can improve the success of IVF or ICSI for couples with unexplained infertility. You will take resveratrol during your IVF cycle to see if it helps with egg quality and pregnancy rates.
This trial tests whether taking Coenzyme Q10 before IVF helps women who are known to respond poorly to ovarian stimulation, with the goal of improving egg quality and pregnancy outcomes.
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
This trial tests two forms of coenzyme Q10 (ubiquinone vs. ubiquinol) to see if either improves egg quality or IVF success. It may be a good fit if you are between 37 and 43, doing your first IVF cycle, and have certain hormone levels within a normal range.
Hear when a new Female Infertility Due to Diminished Ovarian Reserve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.